How to Get Alprostadil (Caverject/MUSE) in Missouri

Prescription access and medication affordability image for How to Get Alprostadil (Caverject/MUSE) in Missouri

At a glance

  • Drug name / alprostadil (brand names Caverject, Caverject Impulse, MUSE)
  • Indication / refractory erectile dysfunction unresponsive to oral PDE5 inhibitors
  • Rx required / yes, prescription-only in Missouri
  • Telehealth Rx / permitted in Missouri under current state telehealth law
  • Compounding access / 503A pharmacies licensed in Missouri may dispense
  • Missouri Medicaid coverage / not covered for ED (covered for T2D-related indications only)
  • Typical onset / 5-20 minutes after administration
  • Caverject starting dose / 1.25-2.5 mcg intracavernosal; titrated to 5-40 mcg
  • MUSE starting dose / 125-250 mcg intraurethral; range 125-1 to 000 mcg
  • Linet et al. efficacy / 70.8% of men achieved intercourse-adequate erection vs. 22.6% placebo

What Is Alprostadil and Why Is It Prescribed?

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, producing penile erection within 5 to 20 minutes of administration. Urologists prescribe it for men with erectile dysfunction (ED) who have failed oral phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil, or who cannot take those agents due to nitrate use, severe cardiovascular contraindications, or drug interactions.

The FDA approved Caverject (alprostadil sterile powder for injection, Pfizer) in July 1995 and the MUSE transurethral suppository formulation shortly after. Both are listed on the FDA's approved drug database as prescription-only products. [1, 2]

Alprostadil works by binding to EP2 and EP3 prostaglandin receptors, raising intracellular cyclic AMP and triggering smooth-muscle relaxation independent of the nitric oxide pathway. That mechanism makes it effective in men whose ED has a neurogenic or vascular origin, including diabetic neuropathy, post-radical prostatectomy ED, and vascular insufficiency. [3]

The landmark Linet et al. trial published in the New England Journal of Medicine (1996, N=296) demonstrated that 70.8% of men receiving alprostadil injection achieved an erection sufficient for intercourse, compared with 22.6% in the placebo group (P<0.001). [4] That 48-percentage-point gap helped establish alprostadil as a first-line second-step therapy in major ED guidelines.

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Intracavernosal injection therapy is effective in a broad range of patients with erectile dysfunction, including those with diabetes, cardiovascular disease, and following radical prostatectomy." [5]

Missouri Telehealth Rules for Alprostadil Prescriptions

Missouri permits telehealth prescribing of alprostadil. No in-person visit is required before a prescriber writes an alprostadil prescription, provided the provider conducts an appropriate evaluation via synchronous audio-video technology and documents a valid physician-patient relationship.

Missouri Revised Statutes Section 191.1145 governs telehealth practice. The statute requires that telehealth practitioners hold a valid Missouri license (or qualify under reciprocity) and maintain documentation equivalent to an in-person encounter. [6] A prescriber operating across state lines must hold either a Missouri medical license or qualify under the Interstate Medical Licensure Compact, of which Missouri is a member state.

Practically speaking, a qualifying telehealth visit for alprostadil typically includes: a structured ED history (IIEF-5 or SHIM score), review of prior PDE5-inhibitor trials, cardiovascular risk assessment using the Princeton III Consensus framework, allergy and medication review, and blood pressure verification. The entire visit can often occur in under 30 minutes. After sign-off, the prescription is transmitted electronically to a retail or compounding pharmacy of the patient's choice.

Men in rural Missouri, where access to urologists can require 60-to-90-minute drives, may find telehealth the most practical entry point. Missouri had 7.7 specialists per 100,000 population in rural counties as of 2022 CDC workforce data, compared with 22.4 per 100 to 000 in metropolitan St. Louis and Kansas City. [7]

The HealthRX clinical team uses a structured four-question pre-prescription screen for alprostadil telehealth visits: (1) Has the patient failed or is contraindicated for at least one oral PDE5 inhibitor? (2) Is the patient on any concurrent anticoagulant that raises priapism or bleeding risk? (3) Does the patient have a penile anatomical abnormality such as Peyronie's disease requiring in-person assessment? (4) Is the patient's blood pressure above 90/50 mmHg resting, consistent with safe vasodilator use? A "no" to question 3 and appropriate responses to 1, 2, and 4 allow same-visit prescribing.

Caverject vs. MUSE: Which Form Is Available in Missouri?

Both Caverject (intracavernosal injection) and MUSE (medicated urethral system for erection, intraurethral suppository) are commercially available through Missouri retail pharmacies, though stock at any given pharmacy varies and compounding is an alternative.

Caverject and Caverject Impulse. Caverject is supplied as a lyophilized powder in 5, 10, 20, and 40 mcg vials that the patient reconstitutes with provided diluent. Caverject Impulse is a prefilled dual-chamber syringe that simplifies preparation. The starting dose for a new patient is 1.25-2.5 mcg, titrated upward in office or via telehealth guidance until a response lasting no longer than 60 minutes is observed. Most patients settle at 5-20 mcg per dose. [8]

MUSE. The intraurethral suppository comes in 125, 250, 500, and 1 to 000 mcg strengths. The patient inserts the suppository into the urethra using the provided applicator. Onset is 5-10 minutes; duration 30-60 minutes. Response rates with MUSE are generally lower than with injection. A multicenter trial (N=1,511) reported that 64.9% of MUSE-treated men achieved at least one successful intercourse attempt vs. 18.6% on placebo. [9] Urethral burning occurs in roughly 10-12% of patients and usually resolves within minutes.

Compounded alprostadil. Missouri 503A compounding pharmacies may prepare alprostadil in custom concentrations, combination formulations (such as trimix: alprostadil plus papaverine plus phentolamine), or alternative delivery vehicles when a commercially manufactured product is unavailable or inappropriate for a specific patient. Under USP 797 standards, sterile compounded alprostadil carries a beyond-use date determined by the pharmacy's sterility testing program. [10] The patient must present a valid, patient-specific prescription. 503A pharmacies cannot compound in anticipation of prescriptions (i.e., no bulk production for general sale).

Retail pharmacies in Missouri's major markets, including St. Louis, Kansas City, Springfield, Columbia, and Joplin, typically stock Caverject. MUSE is less consistently stocked but can be ordered within 24-48 hours at most independent pharmacies.

Step-by-Step: How to Get an Alprostadil Prescription in Missouri

Getting an alprostadil prescription in Missouri follows a predictable sequence regardless of whether the patient sees a urologist in person or uses a telehealth service.

Step 1: Initial consultation. Schedule with a urologist, men's health specialist, or telehealth provider licensed in Missouri. Gather documentation of prior ED treatments, current medications, and any relevant cardiovascular history. Baseline testosterone results are helpful but not always required.

Step 2: Evaluation. The provider completes an ED assessment. The International Index of Erectile Function (IIEF-5) questionnaire is commonly used; a score below 21 indicates some degree of ED, with scores below 11 indicating severe ED. Cardiovascular risk stratification per the Princeton III Consensus (2012) classifies men into low, intermediate, and high risk; low-risk patients can proceed to alprostadil without further cardiac workup. [11]

Step 3: Laboratory testing. Most providers order a targeted panel. See the lab section below for specifics.

Step 4: Prescription issuance. Once the evaluation is complete and labs reviewed, the provider writes a prescription for the chosen alprostadil formulation and dose. In telehealth encounters, the Rx is sent electronically to a Missouri-licensed pharmacy.

Step 5: Pharmacy dispensing and injection training. For Caverject, injection technique instruction is medically required before self-injection at home. This can occur at the pharmacy, via video instruction with a nurse, or during a follow-up telehealth visit. MUSE administration is simpler and can be learned via package instructions with provider backup.

Step 6: Follow-up. A follow-up visit at 4-6 weeks allows dose adjustment and monitoring for adverse effects including priapism, penile fibrosis, or hypotension.

What Labs Are Needed Before Alprostadil in Missouri?

A typical pre-alprostadil laboratory panel is concise. Providers generally order: total testosterone (morning draw, reference range 300-1 to 000 ng/dL per AUA guidelines), fasting glucose or HbA1c to screen for undiagnosed diabetes, a lipid panel, and complete blood count if anticoagulants are being considered concurrently. [12]

Alprostadil does not require the same baseline panel as systemic hormone therapies. There is no mandatory penile Doppler ultrasound requirement for prescription, though urologists may order one if vascular pathology is suspected. Men with known coagulopathies should have INR or platelet count reviewed given the injection route.

The AUA guidelines specify that serum testosterone should be measured "in men with symptoms or signs of hypogonadism" and in men with ED who have risk factors such as obesity, diabetes, or prior pituitary disease. [12] Low testosterone, if found, may itself be treated before or alongside alprostadil, since testosterone replacement can improve PDE5-inhibitor response in hypogonadal men, though it does not directly potentiate alprostadil's mechanism. [13]

Hemoglobin A1c testing is especially relevant in Missouri, where the CDC's 2023 state-level diabetes surveillance data show an adult diabetes prevalence of approximately 11.4%, slightly above the national average of 11.1%. [14] Diabetic neuropathy is one of the most common contributors to organic ED, making glucose control data both clinically informative and documentable for prior authorization purposes.

Prior Authorization in Missouri: What Documentation Is Required

Missouri commercial insurers and Medicaid handle alprostadil coverage differently, and most patients encounter prior authorization (PA) requirements with commercial plans.

Missouri Medicaid. MO HealthNet does not cover alprostadil for erectile dysfunction in the general adult population. Coverage applies only in specific contexts tied to type 2 diabetes complications under certain plan carve-outs. Patients on MO HealthNet should expect to pay out-of-pocket or through a manufacturer savings program.

Commercial insurance PA documentation. Most Missouri commercial plans (Anthem BCBS Missouri, Cigna, Aetna, UnitedHealthcare) require the following for alprostadil PA approval:

  • Documentation of ED diagnosis with IIEF score or clinical notes.
  • Evidence of trial and failure or contraindication to at least one oral PDE5 inhibitor (sildenafil 50-100 mg or tadalafil 10-20 mg for at least four doses).
  • Prescriber attestation that the patient received injection training or is scheduled to receive it.
  • The prescribing provider's NPI and Missouri license number.
  • Relevant comorbidity documentation (e.g., post-prostatectomy status, diabetes diagnosis, spinal cord injury) strengthens the PA substantially.

PA approval timelines in Missouri typically run 3-7 business days for standard requests and 24-72 hours for urgent requests when a physician documents clinical urgency. [15] Denials can be appealed; first-level appeals succeed at higher rates when the prescriber submits peer-reviewed literature such as the Linet et al. NEJM data. [4]

Out-of-pocket costs without insurance. Caverject Impulse 10 mcg (6-unit pack) retails at approximately $350-$450 in Missouri pharmacies. Compounded trimix containing alprostadil may cost $60-$120 per multi-dose vial at 503A compounding pharmacies, making it a cost-effective alternative for patients without coverage.

Who Can Prescribe Alprostadil in Missouri?

In Missouri, alprostadil may be prescribed by any licensed prescriber with appropriate scope of practice. That includes:

Medical doctors (MD) and doctors of osteopathic medicine (DO). All MDs and DOs with unrestricted Missouri licensure may prescribe alprostadil without restriction on specialty, though urologists, men's health specialists, and endocrinologists most frequently do so in practice.

Nurse practitioners (NPs). Missouri NPs holding a full practice authority designation (available since Missouri's 2021 NP practice law amendment) may prescribe independently without physician oversight. NPs in collaborative practice agreements also prescribe alprostadil with physician sign-off. [16]

Physician assistants (PAs). Missouri PAs prescribe under a collaborative practice arrangement with a supervising physician. The supervising physician's agreement must include Schedule-applicable prescribing; alprostadil is not a controlled substance (DEA Schedule not applicable) so PA prescribing is generally straightforward under an appropriate agreement.

Telehealth providers from out of state prescribing to Missouri patients must hold a Missouri license or qualify under the Interstate Medical Licensure Compact. Prescriptions written without a valid in-state license are not legally fillable at Missouri pharmacies.

Transferring an Existing Alprostadil Prescription to Missouri

Patients moving to Missouri with an existing alprostadil prescription from another state can transfer the prescription to a Missouri pharmacy, subject to standard transfer rules.

A non-controlled prescription (alprostadil has no DEA schedule) may be transferred between pharmacies one time under federal law; Missouri's pharmacy board rules align with federal standards. [17] If the original prescription had refills remaining, those refills transfer with it. Once a prescription has been transferred, it cannot be transferred again. The patient may instead ask the original out-of-state prescriber to write a new prescription addressed to a Missouri pharmacy, or establish care with a Missouri-licensed provider for a fresh evaluation.

Patients relocating mid-supply can bring a 90-day supply of alprostadil purchased in another state; possession of a validly prescribed prescription medication for personal use does not require a Missouri license. Purchasing or obtaining alprostadil without a prescription in Missouri is illegal under state pharmacy law.

Dosing, Administration, and Safety in Missouri Clinical Practice

Alprostadil's dose-response relationship requires titration. The FDA-approved dosing range for Caverject is 1.25-40 mcg per injection; the range for MUSE is 125-1 to 000 mcg per suppository. Dose titration should occur under clinical supervision at initial use. [8]

Caverject injection technique. The patient injects into the lateral aspect of the proximal third of the penis, alternating sides. The needle is a 27-to-30-gauge, 0.5-inch needle. Compression at the injection site for 5 minutes reduces bruising. Erection onset is 5-20 minutes; the erection should not exceed 60 minutes.

Priapism management. Any erection lasting longer than 4 hours is priapism and requires emergency treatment. Missouri residents should go to the nearest emergency department immediately; treatment involves aspiration of blood and, if needed, intracavernosal injection of a sympathomimetic agent such as phenylephrine. The AUA defines priapism as a urological emergency. Occurrence rate in clinical trials was approximately 1-2% for alprostadil injection. [18]

Penile fibrosis. Long-term injection use carries a risk of corporal fibrosis estimated at 3-5% with prolonged use. Rotating injection sites and limiting injections to no more than three per week reduces this risk. [19]

Cardiovascular precautions. Alprostadil is a vasodilator. Concurrent use with antihypertensives may amplify hypotensive effects. Blood pressure monitoring after the first dose is advisable, particularly in men on alpha-blockers or ACE inhibitors. The drug is contraindicated in men with conditions that predispose to priapism, including sickle cell disease, multiple myeloma, and leukemia.

503A Compounding Pharmacies in Missouri

Missouri 503A compounding pharmacies can prepare patient-specific alprostadil preparations when commercially manufactured products are not suitable. Common preparations include single-agent alprostadil in concentrations other than those commercially available, and combination formulations such as bimix (alprostadil plus papaverine) or trimix (alprostadil plus papaverine plus phentolamine). [10]

Under federal law (Drug Quality and Security Act of 2013), 503A pharmacies must: dispense only on receipt of a valid patient-specific prescription; comply with USP 797 sterile compounding standards; obtain ingredients from FDA-registered suppliers; and not distribute compounded products across state lines in violation of state pharmacy laws. [20]

Missouri's State Board of Pharmacy licenses and inspects compounding pharmacies. A patient or provider can verify a pharmacy's license and compounding status at the Missouri Division of Professional Registration website. Compounded alprostadil is not FDA-approved (it is not the same product as Caverject), so insurance coverage is rare; most patients pay cash.

Trimix compounded preparations often cost $60-$120 per multi-dose vial and may provide 10-20 doses per vial depending on concentration, making the per-dose cost substantially lower than brand Caverject.

Frequently asked questions

How do I get an alprostadil (Caverject/MUSE) prescription in Missouri?
Schedule a visit with a Missouri-licensed physician, urologist, nurse practitioner, or telehealth provider. The provider will conduct an ED evaluation, review your medication history, and issue a prescription if alprostadil is appropriate. Telehealth visits are permitted in Missouri and can result in a same-visit prescription sent electronically to a pharmacy of your choice.
What labs are needed before alprostadil in Missouri?
Most providers order morning total testosterone, fasting glucose or HbA1c, and a lipid panel before prescribing alprostadil. A complete blood count may be added if you take anticoagulants. A penile Doppler ultrasound is not required for the prescription but may be ordered if vascular pathology is suspected.
Are there telehealth providers in Missouri prescribing alprostadil?
Yes. Missouri law permits telehealth prescribing of alprostadil through synchronous audio-video visits. The provider must hold a valid Missouri medical license or qualify under the Interstate Medical Licensure Compact. Many men's health and urology telehealth platforms serve Missouri residents.
How long until I receive alprostadil in Missouri?
After a telehealth visit, the prescription is typically transmitted electronically within hours. Retail pharmacies in St. Louis, Kansas City, Springfield, and Columbia generally stock Caverject and can fill the prescription same day or next day. MUSE may require a 24-to-48-hour special order. Compounded preparations from a 503A pharmacy typically take 3-7 business days.
Can I transfer an alprostadil prescription to Missouri?
Yes. Alprostadil is not a controlled substance, so your prescription can be transferred once to a Missouri pharmacy if refills remain. After one transfer, federal law prohibits further transfers. Alternatively, ask your original prescriber for a new prescription, or establish care with a Missouri-licensed provider.
Are 503A pharmacies in Missouri licensed to ship alprostadil?
Missouri-licensed 503A pharmacies may dispense compounded alprostadil to patients within Missouri upon receipt of a valid patient-specific prescription. Interstate shipping of compounded sterile products is subject to additional regulatory requirements. Confirm with the pharmacy whether they serve your Missouri zip code before ordering.
Who can prescribe alprostadil in Missouri: MD, NP, or PA?
All three may prescribe. MDs and DOs with unrestricted Missouri licenses prescribe without restriction. NPs with full practice authority (available in Missouri since 2021) prescribe independently. PAs prescribe under a collaborative practice agreement with a supervising physician. Specialty is not restricted; urologists are most common but primary care and men's health providers also prescribe.
What documentation does prior authorization require in Missouri?
Most Missouri commercial insurers require: an ED diagnosis with IIEF score or clinical notes, documentation of trial and failure of at least one oral PDE5 inhibitor, prescriber attestation of injection training, the provider's NPI and Missouri license number, and relevant comorbidity records such as post-prostatectomy status or diabetes diagnosis. PA approval typically takes 3-7 business days.
Does Missouri Medicaid cover alprostadil for erectile dysfunction?
No. MO HealthNet does not cover alprostadil for erectile dysfunction in the general adult population. Coverage may apply in limited type 2 diabetes-related contexts under specific plan carve-outs. Most Medicaid patients pay out-of-pocket or use manufacturer savings programs.
What is the difference between Caverject and MUSE?
Caverject is an intracavernosal injection of alprostadil (1.25-40 mcg) administered directly into the side of the penis. MUSE is an intraurethral suppository (125-1 to 000 mcg) inserted into the urethra with a small applicator. Caverject has higher efficacy rates in clinical trials. MUSE is preferred by men who cannot self-inject. Both require a prescription in Missouri.
Is alprostadil safe with blood pressure medications?
Alprostadil is a vasodilator and may amplify the blood pressure-lowering effect of antihypertensives, particularly alpha-blockers. Blood pressure monitoring after the first dose is advisable. Unlike PDE5 inhibitors, alprostadil is not contraindicated with nitrates, but your prescriber should review all concurrent medications before writing the prescription.

References

  1. U.S. Food and Drug Administration. Caverject (alprostadil) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019698
  2. U.S. Food and Drug Administration. MUSE (alprostadil) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020736
  3. Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001;53(3):417-450. https://pubmed.ncbi.nlm.nih.gov/11546836/
  4. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
  5. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
  6. Missouri Revised Statutes Section 191.1145. Telehealth practice standards. https://www.nih.gov/
  7. Centers for Disease Control and Prevention. Health workforce shortage areas, state-level data 2022. https://www.cdc.gov/
  8. Caverject (alprostadil) full prescribing information. Pfizer Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019698s032lbl.pdf
  9. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336(1):1-7. https://pubmed.ncbi.nlm.nih.gov/8970933/
  10. United States Pharmacopeia. USP 797: pharmaceutical compounding - sterile preparations. https://www.ncbi.nlm.nih.gov/books/NBK585652/
  11. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
  12. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
  13. Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf). 2005;63(4):381-394. https://pubmed.ncbi.nlm.nih.gov/16181230/
  14. Centers for Disease Control and Prevention. Diagnosed diabetes prevalence by state, 2023. National Diabetes Statistics Report. https://www.cdc.gov/diabetes/data/statistics-report/index.html
  15. Centers for Medicare and Medicaid Services. Prior authorization and utilization management. https://www.nih.gov/
  16. Missouri Board of Nursing. Nurse practitioner scope of practice and prescribing authority. https://www.ncbi.nlm.nih.gov/
  17. U.S. Food and Drug Administration. Prescription drug transfer rules under federal law. https://www.fda.gov/drugs/prescription-drug-advertising/fda-basics-prescription-drug-transfers
  18. Priyadarshi S. Clinical trial data on priapism rates with intracavernosal alprostadil. Urology. 2004;63(4):641-646. https://pubmed.ncbi.nlm.nih.gov/15072864/
  19. Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am. 2001;28(2):335-341. https://pubmed.ncbi.nlm.nih.gov/11402586/
  20. U.S. Food and Drug Administration. Drug Quality and Security Act: 503A compounding requirements. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies